What is the current annual EBITDA of NMR?

As of today, NMR annual EBITDA is $4.04B

What is 1-year change in NMR annual EBITDA?

NMR annual EBITDA is up +15.29% year-over-year

What is 3-year change in NMR annual EBITDA?

NMR annual EBITDA is up +164.35% over the past 3 years

How far is NMR annual EBITDA from its all-time high?

NMR annual EBITDA is currently -64.54% below its historical high of $11.38B set on March 31, 2007

How does NMR annual EBITDA rank versus sector peers?

NMR annual EBITDA is higher than 92.53% of companies in Financial Services sector

When is NMR next annual earnings release?

As of today, the next annual earnings release for NMR has not been scheduled

When is NMR next earnings release?

The next earnings release for NMR is on January 29, 2027

When is NMR next earnings release?

The next earnings release for NMR is on January 29, 2027

NMR EBITDA History & Chart Since 1989

Annual EBITDA

$4.04B$535.05M+15.29%

March 31, 2026

Summary

Current Value: As of today, NMR annual EBITDA is $4.04B, up +15.29% on March 31, 2026
Historical Performance: NMR annual EBITDA is up +164.35% over the past 3 years, up +46.85% over the past 5 years
All-Time High Comparison: NMR annual EBITDA is currently -64.54% below its historical high of $11.38B set on March 31, 2007
3-Year Low Comparison: NMR annual EBITDA is +164.35% above its 3-year low of $1.53B reached on an earlier date
Sector Comparison: NMR annual EBITDA is higher than 92.53% of companies in Financial Services sector

EBITDA Chart

beforeafter

Performance

NMR Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Mar 31, 26	$4.04B	+15.3%	+164.3%	+46.9%	-18.7%
Quarterly EBITDA	Sep 30, 26	-	–	–	–	–
TTM EBITDA	Sep 30, 26	-	–	–	–	–
Price	Nov 10, 26	$9.51	+32.1%	+135.4%	+116.1%	+205.8%
PE Ratio	Nov 10, 26	10.91	+23.1%	-18.8%	–	–
Annual Revenue	Mar 31, 26	$31.58B	+1.6%	+72.4%	+107.5%	+97.9%
Annual EPS	Mar 31, 26	$0.79	+8.4%	+260.2%	+72.3%	+760.8%
	Mar 31, 26	$3.58B	+15.7%	+233.8%	+66.9%	-12.2%
Annual Net Income	Mar 31, 26	$2.48B	+9.1%	+267.3%	+64.3%	+566.4%

EBITDA Highs

NMR Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$4.04B	Mar 31, 26	at high
5Y	$4.04B	Mar 31, 26	at high
All	$11.38B	Mar 31, 07	-64.5%

EBITDA Lows

NMR Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$1.53B	N/A	+164.3%
5Y	$1.53B	Mar 31, 23	+164.3%
All	-$5.80B	Mar 1, 99	+169.6%

EBITDA History

Year	Value	Change
2026	$4.04B	+15.3%
2025	$3.50B	+51.2%
2024	$2.32B	+51.7%
2023	$1.53B	-40.1%
2022	$2.55B	-7.3%
2021	$2.75B	-4.5%
2020	$2.88B	+1,146.5%
2019	$230.76M	-92.8%
2018	$3.20B	-11.9%
2017	$3.63B	+78.3%
2016	$2.04B	-68.4%
2015	$6.44B	+44.0%
2014	$4.47B	+3.4%
2013	$4.32B	+81.0%
2012	$2.39B	-51.9%
2011	$4.96B	+19.9%
2010	$4.14B	+219.4%
2009	-$3.47B	-149.2%
2008	$7.05B	-38.1%

Year	Value	Change
2007	$11.38B	+13.4%
2006	$10.03B	+342.6%
2005	$2.27B	-19.5%
2004	$2.82B	-16.1%
2003	$3.36B	-30.3%
2002	$4.81B	-34.4%
2001	$7.34B	+23.7%
2000	$5.93B	+202.3%
1999	-$5.80B	-634.5%
1998	$1.08B	-34.5%
1997	$1.66B	+4.9%
1996	$1.58B	+595.3%
1995	$227.27M	-77.8%
1994	$1.02B	+108.0%
1993	$492.27M	-38.5%
1992	$799.90M	-59.1%
1991	$1.96B	-55.3%
1990	$4.38B	-0.4%
1989	$4.39B	-

FAQ

What is the current annual EBITDA of NMR?: As of today, NMR annual EBITDA is $4.04B
What is 1-year change in NMR annual EBITDA?: NMR annual EBITDA is up +15.29% year-over-year
What is 3-year change in NMR annual EBITDA?: NMR annual EBITDA is up +164.35% over the past 3 years
How far is NMR annual EBITDA from its all-time high?: NMR annual EBITDA is currently -64.54% below its historical high of $11.38B set on March 31, 2007
How does NMR annual EBITDA rank versus sector peers?: NMR annual EBITDA is higher than 92.53% of companies in Financial Services sector
When is NMR next annual earnings release?: As of today, the next annual earnings release for NMR has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

N/A

September 30, 2026

Performance

NMR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	-	–	–	–	–
Annual EBITDA	Mar 31, 26	$4.04B	–	+15.3%	+164.3%	+46.9%
TTM EBITDA	Sep 30, 26	-	–	–	–	–
Price	Nov 10, 26	$9.51	-3.2%	+32.1%	+135.4%	+116.1%
PE Ratio	Nov 10, 26	10.91	-4.3%	+23.1%	-18.8%	–
Quarterly Revenue	Sep 30, 26	$8.31B	-3.5%	+5.5%	+18.6%	+141.1%
Quarterly EPS	Sep 30, 26	$0.22	-28.4%	+5.1%	+180.4%	+2287.9%
	Sep 30, 26	$929.33M	-30.0%	+0.3%	+136.8%	+454.0%
Quarterly Net Income	Sep 30, 26	$668.49M	-31.8%	+2.9%	+171.6%	+1242.2%

Quarterly EBITDA Highs

NMR Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.46B	Jun 30, 26	N/A
3Y	$1.46B	Jun 30, 26	N/A
5Y	$1.46B	Jun 30, 26	N/A
All	$3.50B	Dec 31, 06	N/A

Quarterly EBITDA Lows

NMR Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$812.82M	Mar 31, 26	N/A
3Y	$496.46M	N/A	N/A
5Y	$206.27M	Jun 30, 22	N/A
All	-$4.13B	Dec 31, 08	N/A

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$1.46B	+80.1%
Mar 2026	$812.82M	-17.8%
Dec 2025	$988.28M	-4.5%
Sep 2025	$1.04B	-14.8%
Jun 2025	$1.22B	+64.1%
Mar 2025	$740.78M	-26.4%
Dec 2024	$1.01B	+1.3%
Sep 2024	$993.45M	+30.0%
Jun 2024	$763.94M	+5.0%
Mar 2024	$727.55M	+14.4%
Dec 2023	$636.20M	+28.1%
Sep 2023	$496.46M	+11.4%
Jun 2023	$445.73M	+56.6%
Mar 2023	$284.63M	-59.6%
Dec 2022	$704.60M	+108.3%
Sep 2022	$338.25M	+64.0%
Jun 2022	$206.27M	-62.6%
Mar 2022	$551.58M	-34.3%
Dec 2021	$839.02M	+176.6%
Sep 2021	$303.37M	-64.4%
Jun 2021	$851.72M	+161.0%
Mar 2021	-$1.40B	-199.7%
Dec 2020	$1.40B	+50.1%
Sep 2020	$934.02M	-49.1%
Jun 2020	$1.83B	+2,547.4%
Mar 2020	-$74.92M	-109.6%
Dec 2019	$777.20M	-42.2%
Sep 2019	$1.34B	+61.7%
Jun 2019	$830.64M	+135.1%
Mar 2019	$353.35M	+164.8%
Dec 2018	-$545.64M	-520.1%
Sep 2018	$129.89M	-50.0%
Jun 2018	$259.76M	-54.8%
Mar 2018	$575.24M	-54.0%
Dec 2017	$1.25B	+36.8%
Sep 2017	$913.79M	+6.8%
Jun 2017	$855.24M	-3.7%
Mar 2017	$887.71M	-14.3%
Dec 2016	$1.04B	+6.2%
Sep 2016	$974.56M	+30.1%
Jun 2016	$749.23M	+1,292.8%
Mar 2016	$53.79M	-96.3%
Dec 2015	$1.46B	+337.6%
Sep 2015	$334.18M	-67.9%
Jun 2015	$1.04B	-38.7%
Mar 2015	$1.70B	-11.0%
Dec 2014	$1.91B	+17.2%
Sep 2014	$1.63B	+2.3%
Jun 2014	$1.59B	-4.0%

Month	Value	Change
Mar 2014	$1.66B	-5.3%
Dec 2013	$1.75B	+5.3%
Sep 2013	$1.66B	-21.0%
Jun 2013	$2.10B	-25.3%
Mar 2013	$2.82B	+116.1%
Dec 2012	$1.30B	-12.8%
Sep 2012	$1.49B	+5.9%
Jun 2012	$1.41B	+27.4%
Mar 2012	$1.11B	-37.6%
Dec 2011	$1.77B	+909.5%
Sep 2011	-$219.24M	-111.9%
Jun 2011	$1.85B	+237.5%
Mar 2011	-$1.34B	-181.0%
Dec 2010	$1.66B	+66.9%
Sep 2010	$993.91M	-8.9%
Jun 2010	$1.09B	-35.9%
Mar 2010	$1.70B	+2.3%
Dec 2009	$1.66B	+55.1%
Sep 2009	$1.07B	+114.3%
Jun 2009	$500.53M	+121.6%
Mar 2009	-$2.31B	+44.0%
Dec 2008	-$4.13B	-3,850.5%
Jun 2008	-$104.63M	+72.4%
Mar 2008	-$379.32M	-168.2%
Dec 2007	$556.53M	+315.4%
Sep 2007	-$258.39M	-119.7%
Jun 2007	$1.31B	-58.1%
Mar 2007	$3.13B	-10.4%
Dec 2006	$3.50B	+376.9%
Sep 2006	$733.00M	+84.0%
Jun 2006	$398.43M	-85.3%
Mar 2006	$2.72B	+70.7%
Dec 2005	$1.59B	+45.2%
Sep 2005	$1.10B	+199.1%
Jun 2005	$366.57M	-77.6%
Mar 2005	$1.63B	+186.8%
Dec 2004	$569.57M	+144.5%
Sep 2004	$232.97M	-68.4%
Jun 2004	$738.14M	-44.4%
Mar 2004	$1.33B	+280.4%
Dec 2003	$349.08M	-73.1%
Sep 2003	$1.30B	+140.1%
Jun 2003	$540.78M	+1,637.7%
Mar 2003	-$35.17M	-154.8%
Dec 2002	$64.20M	-74.7%
Sep 2002	$253.58M	+24.9%
Jun 2002	$202.97M	-19.2%
Sep 2001	$251.18M	-35.7%
Jun 2001	$390.43M	-

FAQ

When is NMR next earnings release?: The next earnings release for NMR is on January 29, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

N/A

September 30, 2026

Performance

NMR Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	-	–	–	–	–
Annual EBITDA	Mar 31, 26	$4.04B	–	+15.3%	+164.3%	+46.9%
Quarterly EBITDA	Sep 30, 26	-	–	–	–	–
Price	Nov 10, 26	$9.51	-3.2%	+32.1%	+135.4%	+116.1%
PE Ratio	Nov 10, 26	10.91	-4.3%	+23.1%	-18.8%	–
TTM Revenue	Sep 30, 26	$32.61B	+1.3%	+5.8%	+31.6%	+138.8%
TTM EPS	Sep 30, 26	$0.87	+1.2%	+7.2%	+189.9%	+3147.9%
	Sep 30, 26	$3.82B	+0.1%	+6.6%	+156.2%	+562.1%
TTM Net Income	Sep 30, 26	$2.75B	+0.7%	+7.3%	+184.8%	+10000.0%

TTM EBITDA Highs

NMR TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$4.30B	Jun 30, 26	N/A
3Y	$4.30B	Jun 30, 26	N/A
5Y	$4.30B	Jun 30, 26	N/A
All	$8.67B	Jun 30, 07	N/A

TTM EBITDA Lows

NMR TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$3.98B	Dec 31, 25	N/A
3Y	$1.86B	Dec 31, 23	N/A
5Y	$597.13M	Dec 31, 21	N/A
All	-$6.55B	Mar 31, 09	N/A

TTM EBITDA History

Month	Value	Change
Jun 2026	$4.30B	+6.1%
Mar 2026	$4.05B	+1.8%
Dec 2025	$3.98B	-0.5%
Sep 2025	$4.00B	+1.1%
Jun 2025	$3.96B	+12.9%
Mar 2025	$3.50B	+0.4%
Dec 2024	$3.49B	+11.9%
Sep 2024	$3.12B	+18.9%
Jun 2024	$2.62B	+13.8%
Mar 2024	$2.31B	+23.8%
Dec 2023	$1.86B	-3.5%
Sep 2023	$1.93B	+8.9%
Jun 2023	$1.77B	+15.6%
Mar 2023	$1.53B	-14.8%
Dec 2022	$1.80B	-6.9%
Sep 2022	$1.94B	+1.8%
Jun 2022	$1.90B	-25.4%
Mar 2022	$2.55B	+326.3%
Dec 2021	$597.13M	-48.5%
Sep 2021	$1.16B	-35.2%
Jun 2021	$1.79B	-35.4%
Mar 2021	$2.77B	-32.3%
Dec 2020	$4.09B	+18.0%
Sep 2020	$3.47B	-10.6%
Jun 2020	$3.88B	+34.9%
Mar 2020	$2.88B	-13.0%
Dec 2019	$3.30B	+66.7%
Sep 2019	$1.98B	+158.0%
Jun 2019	$768.24M	+289.2%
Mar 2019	$197.36M	-52.9%
Dec 2018	$419.25M	-81.1%
Sep 2018	$2.21B	-26.1%
Jun 2018	$3.00B	-16.6%
Mar 2018	$3.59B	-8.0%
Dec 2017	$3.91B	+5.8%
Sep 2017	$3.69B	-1.6%
Jun 2017	$3.75B	+2.9%
Mar 2017	$3.65B	+29.6%
Dec 2016	$2.81B	-13.2%
Sep 2016	$3.24B	+24.6%
Jun 2016	$2.60B	-10.1%
Mar 2016	$2.89B	-36.2%
Dec 2015	$4.53B	-8.9%
Sep 2015	$4.98B	-20.6%
Jun 2015	$6.27B	-8.1%
Mar 2015	$6.82B	+0.6%
Dec 2014	$6.78B	+2.4%
Sep 2014	$6.62B	-0.5%
Jun 2014	$6.66B	-7.1%

Month	Value	Change
Mar 2014	$7.17B	-13.9%
Dec 2013	$8.33B	+5.7%
Sep 2013	$7.88B	+2.2%
Jun 2013	$7.71B	+9.9%
Mar 2013	$7.02B	+32.2%
Dec 2012	$5.31B	-8.2%
Sep 2012	$5.78B	+42.1%
Jun 2012	$4.07B	-9.7%
Mar 2012	$4.51B	+119.0%
Dec 2011	$2.06B	+6.0%
Sep 2011	$1.94B	-38.4%
Jun 2011	$3.16B	+31.6%
Mar 2011	$2.40B	-55.9%
Dec 2010	$5.45B	-0.1%
Sep 2010	$5.45B	-1.4%
Jun 2010	$5.53B	+12.0%
Mar 2010	$4.94B	+435.2%
Dec 2009	$922.73M	+118.9%
Sep 2009	-$4.87B	+18.0%
Jun 2009	-$5.95B	+9.2%
Mar 2009	-$6.55B	-41.9%
Dec 2008	-$4.62B	-2,385.1%
Jun 2008	-$185.81M	-115.1%
Mar 2008	$1.23B	-74.0%
Dec 2007	$4.74B	-38.3%
Sep 2007	$7.68B	-11.4%
Jun 2007	$8.67B	+11.8%
Mar 2007	$7.76B	+5.6%
Dec 2006	$7.35B	+35.0%
Sep 2006	$5.44B	-6.3%
Jun 2006	$5.81B	+0.6%
Mar 2006	$5.77B	+23.1%
Dec 2005	$4.69B	+27.9%
Sep 2005	$3.67B	+30.8%
Jun 2005	$2.80B	-11.7%
Mar 2005	$3.17B	+10.7%
Dec 2004	$2.87B	+8.3%
Sep 2004	$2.65B	-28.7%
Jun 2004	$3.71B	+5.6%
Mar 2004	$3.52B	+63.3%
Dec 2003	$2.15B	+15.2%
Sep 2003	$1.87B	+126.9%
Jun 2003	$823.39M	+69.6%
Mar 2003	$485.58M	-6.8%
Dec 2002	$520.75M	+14.1%
Sep 2002	$456.54M	+0.5%
Jun 2002	$454.15M	-29.2%
Sep 2001	$641.61M	+64.3%
Jun 2001	$390.43M	-

FAQ

When is NMR next earnings release?: The next earnings release for NMR is on January 29, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

NMR Official Website www.nomuraholdings.com
NMR Profile on Yahoo Finance finance.yahoo.com/quote/NMR
NMR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nmr